1. Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease
- Author
-
Stanley A. Schwartz, Jeffery Martinez, Zale P. Bernstein, Anardi Agosto-Mojica, Jessica L. Reynolds, Neha Singh, Donald E. Sykes, Ravikumar Aalinkeel, Chiu-bin Hsiao, Joshua M Adams, Bindukumar Nair, and Supriya D. Mahajan
- Subjects
Genetic Markers ,Chemokine ,medicine.medical_treatment ,Biophysics ,Gene Expression ,Single-nucleotide polymorphism ,HIV Infections ,Biochemistry ,Article ,Chemokine receptor ,Gene Frequency ,medicine ,Humans ,Allele ,Molecular Biology ,Gene ,Polymorphism, Genetic ,biology ,Cell Biology ,Prognosis ,Virology ,Interleukin 10 ,Cytokine ,Real-time polymerase chain reaction ,Protein Biosynthesis ,Immunology ,biology.protein ,Disease Progression ,HIV-1 ,Cytokines ,Chemokines - Abstract
Allelic variants of the genes for chemokine receptors and their natural ligands, the chemokines, and cytokines can affect HIV-1 disease progression. This study investigates the level of expression of the CCR5-Delta32, CCR2b-641, RANTES In1.1C, SDF-1 3'A, IL-10-5'-592A and IL-4-589T alleles in two unique HIV-1 infected patient cohorts that represent the two distinct stages of disease progression, namely rapid progressors (RPs) and long term non-progressors (LTNPs) (n=12/group) were recruited. Quantitation of the gene expression of CCR5-Delta32, CCR2b-641, RANTES In1.1C, SDF-1 3'A, IL-10-5'-592A and IL-4-589T in peripheral blood mononuclear leukocytes (PBML) isolated from patients was performed by real time, quantitative (Q)-PCR using DNA was isolated from PBML. We observed that expression of these HIV-protective alleles was generally greater in the LTNP cohort than the RP cohort. LTNPs expressed more of the protective chemokine, SDF-1alpha than RPs, and no statistically significant difference was observed in RANTES production between the LTNPs and RPs. The LTNPs expressed significantly less amounts of cytokines IL-10 and IL-4 as compared to the RPs. Our results demonstrate that gene polymorphisms for CCR5-Delta32, CCR2b-641, RANTES In1.1C, SDF-1 3'A, IL-10-5'-592A and IL-4-589T may be used as clinical markers to predict progression of HIV-1 infections.
- Published
- 2010